Abstract
Type 2 diabetes and obesity are common metabolic disorders characterized by resistance to the actions of insulin to stimulate skeletal muscle glucose disposal. Insulin-resistant muscle has defects at several steps of the insulin-signaling pathway, including decreases in insulin-stimulated insulin receptor and insulin receptor substrate-1 tyrosine phosphorylation, and phosphatidylinositol 3-kinase (Pl 3-kinase) activation. One approach to increase muscle glucose disposal is to reverse/improve these insulin-signaling defects. Weight loss and thiazolidinediones (TZDs) improve glucose disposal, in part, by increasing insulin-stimulated insulin receptor and IRS-1 tyrosine phosphorylation and PI 3-kinase activity. In contrast, physical training and metformin improve whole-body glucose disposal but have minimal effects on proximal insulin-signaling steps. A novel approach to reverse insulin resistance involves inhibition of the stress-activated protein kinase Jun N-terminal kinase (JNK) and the protein tyrosine phosphatases (PTPs). A different strategy to increase muscle glucose disposal is by stimulating insulin-independent glucose transport. AMP-activated protein kinase (AMPK) is an enzyme that works as a fuel gauge and becomes activated in situations of energy consumption, such as muscle contraction. Several studies have shown that pharmacologic activation of AMPK increases glucose transport in muscle, independent of the actions of insulin. AMPK activation is also involved in the mechanism of action of metformin and adiponectin. Moreover, in the hypothalamus, AMPK regulates appetite and body weight. The effect of AMPK to stimulate muscle glucose disposal and to control appetite makes it an important pharmacologic target for the treatment of type 2 diabetes and obesity.
Similar content being viewed by others
References
DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., and Felber, J. P. (1981). Diabetes 30, 1000–1007.
Grillo, S., Gremeaux, T., Le Marchand-Brustel, Y., and Tanti, J. (1999). FEBS Lett. 461, 277–279.
Wiek, K. L. and Liu, F. (2001). Curr. Drug Targets Immune Endocr. Metabol. Disord. 1, 209–221.
Hill, M. M., Clark, S. F., Tucker, D. F., Birnbaum, M. J., James, D. E., and Macaulay, S. L. (1999). Mol. Cell Biol. 19, 7771–7781.
Cho, H., Mu, J., Kim, J. K., et al. (2001). Science 292, 1728–1731.
Farese, R. V., Sajan, M. P., and Standaert, M. L. (2005). Biochem. Soc. Trans. 33, 350–353.
Kim, Y. B., Kotani, K., Ciaraldi, T. P., Henry, R. R., and Kahn, B. B. (2003). Diabetes 52, 1935–1942.
Zeigerer, A., McBrayer, M. K., and McGraw, T. E. (2001). Mol. Biol. Cell. 15, 4406–4415.
Kido, Y., Nakae, J., and Accili, D. (2001). J. Clin. Endocrinol. Metab. 86, 972–979.
Caro, J. F. (1991). J. Clin. Endocrinol. Metab. 73, 691–695.
DeFronzo, R. A., Sherwin, R. S., and Kraemer, N. (1987). Diabetes 36, 1379–1385.
Zierath, J. R., Handberg, A., Tally, M., and Wallberg-Henriksson, H. (1996). Diabetologia 39, 306–313.
Shulman, G. I. (2000). J. Clin. Invest. 106, 171–176.
Garvey, W. T., Maianu, L., Zhu, J. H., Brechtel-Hook, G., Wallace, P., and Baron, A. D. (1998). J. Clin. Invest. 101, 2377–2386.
Caro, J. F., Sinha, M. K., Raju, S. M., et al. (1987). J. Clin. Invest. 79, 1330–1337.
Goodyear, L. J., Giorgino, F., Sherman, L. A., Carey, J., Smith, R. J., and Dohm, G. L. (1995). J. Clin. Invest. 95, 2195–2204.
Zierath, J. R., Krook, A., and Wallberg-Henriksson, H. (1998). Mol. Cell. Biochem. 182, 153–160.
Bjornholm, M., Kawano, Y., Lehtihet, M., and Zierath, J. R. (1997). Diabetes 46, 524–527.
Cusi, K., Maezono, K., Osman, A., et al. (2000). J. Clin. Invest. 105, 311–320.
Mandarino, L. J., Consoli, A., Jain, A., and Kelley, D. E. (1996). Am. J. Physiol. 270, E463–470.
Johnson, A. B., Argyraki, M., Thow, J. C., et al. (1991). Metabolism 40, 252–260.
Damsbo, P., Vaag, A., Hother-Nielsen, O., and Beck-Nielsen, H. (1991). Diabetologia 34, 239–245.
Kim, Y. B., Nikoulina, S. E., Ciaraldi, T. P., Henry, R. R., and Kahn, B. B. (1999). J. Clin. Invest. 104, 733–741.
Karlsson, H. K., Zierath, J. R., Kane, S., Krook, A., Lienhard, G. E., and Wallberg-Henriksson, H. (2005). Diabetes 54, 1692–1697.
Boden, G., Lebed, B., Schatz, M., Homko, C., and Lemieux, S. (2001). Diabetes 50, 1612–1617.
Perseghin, G., Scifo, P., De Cobelli, F., et al. (1999). Diabetes 48, 1600–1606.
Kim, J. K., Kim, Y. J., Fillmore, J. J., et al. (2001). J. Clin. Invest. 108, 437–446.
Itani, S. I., Zhou, Q., Pories, W. J., MacDonald, K. G., and Dohm, G. L. (2000). Diabetes 49, 1353–1358.
Schmitz-Peiffer, C., Browne, C. L., Oakes, N. D., et al. (1997). Diabetes 46, 169–178.
Goodyear, L. J., Giorgino, F., Balon, T. W., Condorelli, G., and Smith, R. J. (1995). Am. J. Physiol. 268, E987–995.
Richter, E. A., Mikines, K. J., Galbo, H., and Kiens, B. (1989). J. Appl. Physiol. 66, 876–885.
Wojtaszewski, J. F., Hansen, B. F., Kiens, B., and Richter, E. A. (1997). Diabetes 46, 1775–1781.
Lee, A. D., Hansen, P. A., and Holloszy, J. O. (1995). FEBS Lett. 361, 51–54.
Lund, S., Holman, G. D., Schmitz, O., and Pedersen, O. (1995). Proc. Natl. Acad. Sci. USA 92, 5817–5821.
Yeh, J. I., Gulve, E. A., Rameh, L., and Birnbaum, M. J. (1995). J. Biol. Chem. 270 12107–2111.
Wojtaszewski, J. F., Higaki, Y., Hirshman, M. F., et al. (1999). J. Clin. Invest. 104, 1257–1264.
Hughes, V. A., Fiatarone, M. A., Fielding, R. A., et al. (1993). Am. J. Physiol. 264, E855–862.
Luciano, E., Carneiro, E. M., Carvalho, C. R., et al. (2002). Eur. J. Endocrinol. 147, 149–157.
Mikines, K. J., Farrell, P. A., Sonne, B., Tronier, B., and Galbo, H. (1998). J. Appl. Physiol. 64, 988–999.
Richter, E. A., Garetto, L. P., Goodman, M. N., and Ruderman, N. B. (1982). J. Clin. Invest. 69, 785–793.
Wojtaszewski, J. F., Hansen, B. F., Gade, J., et al. (2000). Diabetes 49, 325–331.
Zhou, Q. and Dohm, G. L. (1997). Biochem. Biophys. Res. Commun. 236, 647–650.
Howlett, K. F., Sakamoto, K., Hirshman, M. F., et al. (2002). Diabetes 51, 479–483.
Houmard, J. A., Shaw, C. D., Hickey, M. S., and Tanner, C. J. (1999). Am. J. Physiol. 277, E1055–1060.
Christ-Roberts, C. Y., Pratipanawatr, T., Pratipanawatr, W., et al. (2004). Metabolism 53, 1233–1242.
Daugaard, J. R., Nielsen, J. N., Kristiansen S., Andersen, J. L., Hargreaves, M., and Richter, E. A. (2000). Diabetes 49, 1092–1095.
Stallknecht, B., Larsen, J. J., Mikines, K. J., Simonsen, L., Bulow, J., and Galbo, H. (2000). Am. J. Physiol. Endocrinol. Metab. 279, E376–385.
Phillips, S. M., Han, X. X., Green, H. J., and Bonen, A. (1996). Am. J. Physiol. 270, E456–462.
Colman, E., Katzel, L. I., Rogus, E., Coon, P., Muller, D., and Goldberg, A. P. (1995). Metabolism 44, 1502–1508.
Goodpaster, B. H., Kelley, D. E., Wing R. R., Meier, A., and Thaete, F. L. (1999). Diabetes 48, 839–847.
Niskanen, L., Uusitupa, M., Sarlund, H., Siitonen, O., Paljarvi, L., and Laakso, M. (1996). Int. J. Obes. Relat. Metab. Disord. 20, 154–160.
Pender, C., Goldfine, I. D., Tanner, C. J., et al. (2004). Int. J. Obes. Relat. Metab. Disord. 28, 363–369.
Sarabia, V., Lam, L., Burdett, E., Leiter, L. A., and Klip, A. (1992). J. Clin. Invest. 90, 1386–1395.
Rossetti, L., DeFronzo, R. A., Gherzi, R., et al. (1990). Metabolism 39, 425–435.
Lord, J. M., Puah, J. A., Atkins, T. W., and Bailey, C. J. (1985). J. Pharm. Pharmacol. 37, 821–823.
Galuska, D., Nolte, L. A., Zierath, J. R., and Wallberg-Henriksson, H. (1994). Diabetologia 37, 826–832.
Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., and Klip, A. (1992). Endocrinology 131, 1165–1173.
Matthaei, S., Reibold, J. P., Hamann, A., et al. (1993). Endocrinology 133, 304–311.
Holle, A., Mangels, W., Dreyer, M., Kuhnau, J., and Rudiger, H. W. (1981). N. Engl. J. Med. 305, 563–566.
Santos, R. F., Nomizo, R., Bopsco, A., Wajchenberg, B. L., Reaven, G. M., and Azhar, S. (1997). Diabetes Metab. 23, 143–148.
Wu, M. S., Johnston, P., Sheu, W. H., et al. (1990). Diabetes Care 13, 1–8.
Fantus, I. G. and Brosseau R. (1986). J. Clin. Endocrinol. Metab. 63, 898–905.
Stith, B. J., Goalstone, M. L., Espinoza, R., Mossel, C., Roberts, D., and Wiernsperger, N. (1996). Endocrinology 137, 2990–2999.
Kim, Y. B., Ciaraldi, T. P., Kong, A., et al. (2002). Diabetes 51, 443–448.
Bays, H., Mandarino, L., and DeFronzo, R. A. (2004). J. Clin. Endocrinol. Metab. 89, 463–478.
Kahn, C. R., Chen, L., and Cohen, S. E. (2000). J. Clin. Invest. 106, 1305–1307.
Zierath, J. R., Ryder, J. W., Doebber, T., et al. (1998). Endocrinology 139, 5034–5041.
Vidal-Puig, A. J., Considine, R. V., Jimenez-Linan M., et al. (1997). J. Clin. Invest. 99, 2416–2422.
Kruszynska, Y. T., Mukherjee, R., Jow, L., Dana, S., Paterniti, J. R., and Olefsky, J. M. (1998). J. Clin. Invest. 101, 543–548.
Miyazaki, Y., Mahankali, A., Wajcberg, E., Bajaj, M., Mandarino, L. J., and DeFronzo, R. A. (2004). J. Clin. Endocrinol. Metab. 89, 4312–4319.
Mayerson, A. B., Hundal, R. S., Dufour, S., et al. (2002). Diabetes 51, 797–802.
Miyazaki, Y., He, H., Mandarino, L. J., and DeFronzo, R. A. (2003). Diabetes 52, 1943–1950.
Beeson, M., Sajan, M. P., Dizon, M., et al. (2003). Diabetes 52, 1926–1934.
Karlsson, H. K., Hallsten, K., Bjornholm, M., et al. (2005). Diabetes 54, 1459–1467.
Gupta, S., Barrett, T., Whitmarsh, A.J., et al. (1996). EMBO J. 15, 2760–2770.
Aguirre, V., Uchida, T., Yenush, L., Davis, R., and White, M. F. (2000). J. Biol. Chem. 275, 9047–9054.
Hirosumi, J., Tuncman, G., Chang, L., et al. (2002). Nature 420, 333–336.
Bennett, B. L., Satoh, Y., and Lewis, A. J. (2003). Curr. Opin. Pharmacol. 3, 420–425.
Kenner, K. A., Anyanwu, E., Olefsky, J. M., and Kusari, J. (1996). J. Biol. Chem. 271, 19810–19816.
Cong, L. N., Chen, H., Li, Y., Lin, C. H., Sap, J., and Quon, M. J. (1999). Biochem. Biophys. Res. Commun. 255, 200–207.
Egawa, K., Maegawa, H., Shimizu, S., et al. (2001). J. Biol. Chem. 276, 10207–10211.
Shimizu, S., Maegawa, H., Egawa, K., Shi, K., Bryer-Ash, M., and Kashiwagi, A. (2002). Endocrinology 143, 4563–4569.
Zabolotny, J. M., Haj, F. G., Kim, Y. B., et al. (2004). J. Biol. Chem. 279, 24844–24851.
Klaman, L. D., Boss, O., Peroni, O. D., et al. (2000). Mol. Cell. Biol. 20, 5479–5489.
Elchebly, M., Payette, P., Michaliszyn, E., et al. (1999). Science 283, 1544–1548.
Rondinone, C. M., Trevillyan, J. M., Clampit, J., et al. (2002). Diabetes 51, 2405–2411.
Zinker, B. A., Rondinone, C. M., Trevillyan, J. M., et al. (2002). Proc. Natl. Acad. Sci. USA 99, 11357–11362.
Hardie, D. G. and Carling, D. (1997). Eur. J. Biochem 246, 259–273.
Kemp, B. E., Mitchelhill, K. I., Stapleton, D., Michell, B. J., Chen, Z. P., and Witters, L. A. (1999). Trends Biochem. Sci. 24, 22–25.
Hayashi, T., Hirshman, M. F., Fujii, N., Habinowski, S. A., Witters, L. A., and Goodyear, L. J. (2000). Diabetes 49, 527–531.
Hardie, D. G. and Hawley, S. A. (2001). Bioessays 23, 1112–1119.
Fujii, N., Hirshman, M. F., Kane, E. M., et al. (2005). J. Biol. Chem. 280, 39033–39041.
Stapleton, D., Mitchelhill, K. I., Gao, G., et al. (1996). J. Biol. Chem. 271, 611–614.
Hawley, S. A., Boudeau, J., Reid, J. L., et al. (2003). J. Biol. 2, 28.
Woods, A., Johnstone, S. R., Dickerson, K., et al. (2003). Curr. Biol. 13, 2004–2008.
Shaw, R. J., Kosmatka, M., Bardeesy, N., et al. (2004). Proc. Natl. Acad. Sci. USA 101, 3329–3335.
Winder, W. W. (2001). J. Appl. Physiol. 91, 1017–1028.
Musi, N., Hayashi, T., Fujii, N., Hirshman, M. F., Witters, L. A., and Goodyear, L. J. (2001). Am. J. Physiol. Endocrinol. Metab. 280, E677–684.
Hayashi, T., Hirshman, M. F., Kurth, E. J., Winder, W. W., and Goodyear, L. J. (1998). Diabetes 47, 1369–1373.
Bergeron, R., Russell, R. R. 3rd., Young, L. H., et al. (1999). Am. J. Physiol. 276, E938–944.
Villet, B., Andrelli, F., Jorgensen, S. B., et al. (2003). J. Clin. Invest. 111, 91–98.
Mu, J., Brozinick, J. T. Jr., Valladares, O., Bucan, M., and Birnbaum, M. J. (2001). Mol. Cell. 7, 1085–1094.
Jorgensen, S. B., Viollet, B., Andreelli, F., et al. (2004). J. Biol. Chem. 279, 1070–1079.
Cusi, K. D. and De Fronzo, R. A. (1998). Diabetes Rev. 6, 89–131.
Hother-Nielsen, O., Schmitz, O., Andersen, P. H., Beck-Nielsen, H., and Pedersen, O. (1989). Acta Endocrinol. (Copenh.) 120, 257–265.
Zhou, G., Myers, R., Li, Y., et al. (2001). J. Clin. Invest. 108, 1167–1174.
Musi, N., Hirshman, M. F., Nygren, J., et al. (2002). Diabetes 51, 2074–2081.
Fruebis, J., Tsao, T. S., Javorschi, S., et al. (2001). Proc. Natl. Acad. Sci. USA 98, 2005–2010.
Yamauchi, T., Kamon, J., Minokoshi, Y., et al. (2002). Nat. Med. 8, 1288–1295.
Hotta, K., Funahashi, T., Bodkin, N. L., et al. (2001). Diabetes 50, 1126–1133.
Cnop, M., Havel, P. J., Utzschneider, K. M., et al. (2003). Diabetologia 46, 459–469.
Tschritter, O., Fritsche, A., Thamer, C., et al. (2003). Diabetes 52, 239–243.
Tomas, E., Tsao, T. S., Saha, A. K., et al. (2002). Proc. Natl. Acad. Sci. USA 99, 16309–16313.
Wu, X., Motoshima, H., Mahadev, K., Stalker, T. J., Scalia, R., and Goldstein, B. J. (2003). Diabetes 52, 1355–1363.
Andersson, U., Filipsson, K., Abbott, C. R., et al. (2004). J. Biol. Chem. 279, 12005–12008.
Minokoshi, Y., Alquier, T., Furukawa, N., et al. (2004). Nature 428, 569–574.
Kim, E. K., Miller, I., Aja, S., et al. (2004). J. Biol. Chem. 279, 19970–19976.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Musi, N., Goodyear, L.J. Insulin resistance and improvements in signal transduction. Endocr 29, 73–80 (2006). https://doi.org/10.1385/ENDO:29:1:73
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:29:1:73